Rhythm Pharmaceuticals buy Citigroup Inc.
Start price
27.11.25
/
50%
€93.00
Target price
27.11.26
€117.12
Performance (%)
-18.82%
Price
09:47
?
Summary
This prediction is currently active. The price of Rhythm Pharmaceuticals has decreased since the start of the prediction. Compared to the start price this results in a performance of -18.82%. This prediction currently runs until 27.11.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Rhythm Pharmaceuticals | 0.685% | 0.685% |
| iShares Core DAX® | 0,79 % | 1,97 % |
| iShares Nasdaq 100 | 4,23 % | 4,34 % |
| iShares Nikkei 225® | 3,29 % | 6,99 % |
| iShares S&P 500 | 2,50 % | 2,76 % |
Comments by Citigroup_Inc_ for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals (NASDAQ:RYTM) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $136.00 price target on the stock.
Ratings data for RYTM provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€77.50
17.03.26
17.03.26
€113.94
17.03.27
17.03.27
-2.58%
09:47
09:47
